Results 91 to 100 of about 70,470 (286)

Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood [PDF]

, 2017
Background: The Roche CARDIAC proBNP point-of-care (POC) test is the first test intended for the quantitative determination of N-terminal pro-brain natriuretic peptide (NT-proBNP) in whole blood as an aid in the diagnosis of suspected congestive heart ...
Collinson, Paul O., Dikkeschei, Bert, Gaze, David C., Guerti, Khadija, Gurr, Eberhard, Haass, Markus, Hayen, Wiebke, Hechler, Christoph, Katus, Hugo A., Klopprogge, Kai, Nelles, Manfred, Printzen, Gert, Schulz, Ilse, van Hoof, Viviane, van Waes, Carl, Zerback, Rainer, Zugck, Christian   +16 more
core  

Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I [PDF]

, 2015
Background: To evaluate diagnostic and long-term prognostic values of hFABP compared to NT-proBNP and troponin I (TnI) in patients presenting to the emergency department (ED) suspected of acute heart failure (AHF).
Ahmad-Nejad, Parviz, Akin, Ibrahim, Behnes, Michael, Borggrefe, Martin, Brückmann, Martina, Espeter, Florian, Hoffmann, Ursula, Lang, Siegfried, Neumaier, Michael, Weiß, Christel   +9 more
core   +1 more source

Cardiac damage biomarkers and heart rate variability following a 118-km mountain race: relationship with performance and recovery [PDF]

, 2019
This study aimed to assess the release of cardiac damage biomarkers jointly with cardiac autonomic modulation after a mountain ultramarathon. Such knowledge and the possible relationship of these markers with race time is of primary interest to establish
Collado-Boira, Eladio, Hernando, Barbara, MARTINEZ-NAVARRO, IGNACIO, Panizo, Nayara, Sánchez-Gómez, Juan M.   +4 more
core   +1 more source

Biomarkers in acute coronary syndromes and their role in diabetic patients [PDF]

, 2005
Diabetic patients with acute coronary syndromes are at high risk for cardiovascular complications but risk stratification in these patients remains challenging.
Christopher Heeschen, Heeschen C, James SK, Khaliq A, Luttun A, Mak KH   +5 more
core   +1 more source

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source

Direct comparison of B-Type Natriuretic Peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data [PDF]

, 2006
Background: The B-type or brain natriuretic peptides (BNP) and the amino-terminal probrain natriuretic peptide (NT-proBNP) are good markers of prognosis and diagnosis in chronic heart failure (HF). It is unclear, however, whether differences in their
CLERICO, ALDO, E. D. Missov, F. Cugini, G. Tognoni, I. S. Anand, J. N. Cohn, L. Angelici, R. Latini, S. Barlera, S. Masson, T. Vago   +10 more
core   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function [PDF]

, 2018
Clinical biomarkers of cardiac function could also be monitored postmortem. Among the natriuretic peptides, the aminoterminal portion of pro-brain natriuretic peptide (NT-proBNP) appears to be a more reliable postmortem tool than the BNP, owing to its ...
Augsburger, Marc, Bollmann, Marc, Donzé, Nicolas, Faouzi, Mohamed, Mangin, Patrice, Michaud, Katarzyna, Sabatasso, Sara   +6 more
core  

In search of an efficient strategy to monitor disease status of chronic heart failure outpatients [PDF]

, 2017
_Introduction_ Blood biomarkers have the potential to monitor the severity of chronic heart failure (CHF). Studies correlating repeated measurements of blood biomarkers with repeatedly assessed New York Heart Association (NYHA) class over a prolonged ...
Akkerhuis, K.M. (Martijn), Anroedh, S.S. (Sharda), Battes, L.C. (Linda), Boersma, H. (Eric), Boven, N. (Nick) van, Caliskan, K.C. (Kadir), Constantinescu, A.A. (Alina), Cornel, J.H. (Jan), Kardys, I. (Isabella), Manintveld, O.C. (Olivier), Umans, V.A.W.M. (Victor), Yassi, W. (W.)   +11 more
core   +4 more sources

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source